Abstract
Piperlongumine (PL), a single component isolated from Piper longum, has been reported to possess anti-inflammatory, antibacterial, antiangiogenic, antioxidant, antitumor, and antidiabetic activities. However, its role in cardiac fibrosis remains to be clarified. Therefore, we determined the effects of PL on cardiac fibroblasts (CFs) proliferation, and extracellular matrix (ECM) production under angiotensin II (Ang II) conditions, and further investigated the underlying molecular mechanism. Our data revealed that PL inhibited the proliferation and migration of CFs induced by Ang II. In addition, PL blocked the transformation of CFs to myofibroblasts induced by Ang II, as well as decreased cellular reactive oxygen species (ROS) production and malondialdehyde level in Ang II-stimulated CFs. Furthermore, PL significantly suppressed the Ang II-increased phosphorylation of extracellular regulated protein kinase 1/2 (ERK1/2) in CFs. Taken together, the results of the current study demonstrated that PL inhibits Ang II-induced cell proliferation, migration, and ECM expression in CFs through the inactivation of the ERR1/2 signaling pathway. These data strongly suggest that PL may be a promising therapeutic candidate for the treatment of ...Continue Reading
References
Apr 1, 1994·Circulation Research·D C CrawfordP Brecher
Jun 1, 1993·Circulation Research·W SchorbK M Baker
Oct 1, 1996·Molecular and Cellular Biochemistry·H Ju, I M Dixon
Jul 6, 2000·Trends in Cardiovascular Medicine·T MatsusakaI Ichikawa
Oct 13, 2001·Circulation Research·M SanoS Ogawa
Feb 25, 2003·Journal of the American College of Cardiology·Teresa M SecciaGian Paolo Rossi
Sep 7, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jennifer E NaugleJ Gary Meszaros
Jan 16, 2008·Hypertension·Erik R OlsonJ Gary Meszaros
Jun 27, 2008·Molecular and Cellular Biochemistry·Wenyuan ZhaoYao Sun
Aug 13, 2008·Phytotherapy Research : PTR·Byeoung-Soo ParkSung-Eun Lee
Jun 12, 2010·Circulation Research·Andrew Leask
Jul 17, 2010·Journal of Cellular Physiology·Guido KrenningRaghu Kalluri
Aug 5, 2010·Journal of Hypertension·Carlos B StehrCarlos E Fardella
Dec 22, 2011·International Journal of Inflammation·Yasuhiro Yoshimatsu, Tetsuro Watabe
Mar 8, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Min YuDu-Juan Yu
Sep 18, 2012·Biochimica Et Biophysica Acta·Wei Chen, Nikolaos G Frangogiannis
Sep 22, 2012·Biochemical and Biophysical Research Communications·Dong Ju SonYoung Hyun Park
May 8, 2013·Cellular and Molecular Life Sciences : CMLS·Ping KongNikolaos G Frangogiannis
Aug 31, 2013·Cardiovascular & Hematological Disorders Drug Targets·Yudi PurnomoPaul J Lijnen
Jan 18, 2014·British Journal of Cancer·P MakhovV M Kolenko
Jan 15, 2015·Journal of Molecular and Cellular Cardiology·Xianwei WangJawahar L Mehta
Apr 1, 2015·Journal of Cellular and Molecular Medicine·Xizhong SuiDacheng Wang
Apr 30, 2015·PloS One·Rui LiXiaoping Ji
Oct 22, 2015·Cardiovascular Toxicology·Mingming ZhangDongdong Sun
Oct 30, 2015·International Journal of Cardiology·J-T SiewekeM Brehm
Jan 12, 2016·BMC Cardiovascular Disorders·Han WuBiao Xu
Mar 18, 2016·Cardiology·Jianquan Zhao, Han Lei
Nov 7, 2016·Experimental Cell Research·Radiosa GalliniJohanna Andrae
Dec 25, 2016·Free Radical Biology & Medicine·Sun Mi GuJin Tae Hong
Mar 6, 2017·Molecular Medicine Reports·Hong-Tao ZhouGui-Ming Zhou
Citations
Dec 31, 2019·Kardiologiia·A E KostyuninO L Barbarash
Mar 2, 2021·Frontiers in Cardiovascular Medicine·Wenxiang ShiWei Sun
Mar 28, 2021·Biochemical and Biophysical Research Communications·Hui-Hui WuGuo-Hai Su
Oct 12, 2020·Pharmacology & Therapeutics·Chunhui ZhaoLuqi Huang
Apr 24, 2021·Journal of Ethnopharmacology·Meizhong PengJianfeng Chu